|
At the moment, there is no cure for Alzheimer's Disease. For some people in the early or middle stages of Alzheimer's Disease, certain medications may alleviate some cognitive symptoms or keep the symptoms from getting worse for a limited time. Other medications may help control behavioural symptoms such as sleeplessness, agitation, wandering, anxiety and depression.
Follow the links below to find information relating to the latest research and treatments for Alzheimer's Disease.
Reviewed May 2008
Printer friendly page
Related HealthInsite Topics
| Results 1 to 16 displayed. |
| Title: |
Dementia
|
| Publisher: |
Australian Prescriber
|
| Description: |
Alzheimer's disease is the most common type of dementia. These patients have difficulty remembering recent events and may notice problems with speech and thinking.
|
| Date: |
Feb 2009
|
| Title: |
Alzheimer's disease and exercise
|
| Publisher: |
Better Health Channel
|
| Description: |
People with Alzheimer's disease can benefit from exercise. Physical activity can help to reduce depression for people with Alzheimer's disease and protect against falls and fractures.
|
| Date: |
Mar 2008
|
| Title: |
Alzheimer's disease - latest research
|
| Publisher: |
Better Health Channel
|
| Description: |
Alzheimer's disease is one type of dementia. It is a progressive and eventually fatal disease of the brain. It impairs higher brain functions such as memory, thinking and personality. Current research is looking at causes, treatment and possible prevention of Alzheimer's disease.
|
| Date: |
Mar 2008
|
| Title: |
Down syndrome and Alzheimer's
|
| Publisher: |
Better Health Channel
|
| Description: |
The connection between Down syndrome and Alzheimer's disease is complex. Studies of the brains of people with Down syndrome reveal that, by the age of 40, almost all develop the brain changes characteristic of Alzheimer's disease. Not every person with Down syndrome will develop the clinical symptoms of Alzheimer's disease.
|
| Date: |
Oct 2007
|
| Title: |
Subsidies for Aricept, Exelon and Reminyl: what are the conditions?
|
| Publisher: |
Alzheimer's Australia
|
| Description: |
Aricept, Exelon and Reminyl are now approved for listing on the Pharmaceutical Benefits Schedule (PBS) but only for people with mild to moderate Alzheimer's disease and subject to certain conditions. This Update Sheet provides information about the conditions that need to be met in order to receive these medications at the subsidised rate.
|
| Date: |
Oct 2006
|
| Title: |
What now for Alzheimer's Disease? An epidemiological evaluation of the AD2000 trial (Editorial)
|
| Publisher: |
Australian Prescriber
|
| Description: |
In recent years, acetylcholinesterase inhibitors have been approved for the treatment of Alzheimer's disease. This has been mainly on the strength of many randomised placebo-controlled trials showing a statistically significant improvement in cognitive, functional and behavioural scores mainly at 12 and 24 weeks.
|
| Date: |
Dec 2005
|
| Title: |
Ebixa (Memantime) - What is it?
|
| Publisher: |
Alzheimer's Australia
|
| Description: |
A drug has been released in the UK and parts of Europe which could help delay the more severe symptoms of Alzheimer's disease. This drug is currently available in Australia on private prescription. The generic name for this drug is memantine. It is marketed under the name of Ebixa by Lundbeck Australia Pty Ltd.
|
| Date: |
Jul 2005
|
| Title: |
Research
|
| Publisher: |
Alzheimer's Australia
|
| Description: |
This help sheet provides an overview of current research into Alzheimer's disease and discusses some of the issues involved in participating research studies.
|
| Date: |
Jul 2005
|
| Title: |
New drugs - Aripiprazole and Memantine
|
| Publisher: |
Australian Prescriber
|
| Description: |
Some of the views expressed in the following notes on newly approved products should be regarded as tentative, as there may have been little experience in Australia of their safety or efficacy.
|
| Date: |
Oct 2003
|
| Title: |
2002 - HT and Alzheimer Dementia
|
| Publisher: |
The Jean Hailes Foundation for Women's Health
|
| Description: |
A recent report published in the JAMA adds further evidence favouring a protective effect of long-term postmenopausal hormone therapy (HT) on the risk of developing Alzheimer's Dementia.
|
| Date: |
Sep 2003
|
| Title: |
Alzheimer's disease
|
| Publisher: |
myDr
|
| Description: |
Alzheimer`s disease is a progressive disease which attacks brain cells. It accounts for between 50 per cent and 70 per cent of all dementia cases.
|
| Date: |
Aug 2002
|
| Title: |
Alzheimer's disease progression
|
| Publisher: |
myDr
|
| Description: |
People who have Alzheimer's disease differ in the sorts of problems they have and the speed at which they become worse.
|
| Date: |
Mar 2002
|
| Results 1 to 16 displayed. |
|